Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus

Gilead Sciences, Inc. (GILD) and Vir Biotechnology, Inc. (VIR) have entered into a clinical collaboration to evaluate therapeutic combination strategies aimed at developing a functional cure for chronic hepatitis B virus.